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http:WHAT THIS PAPER ADDS
The study demonstrates that on the basis of clinical status alone, the patency of the endovascularly treated
lesion is difﬁcult to assess, as in 30% of the patients the clinical presentation and toe pressures did not correlate
with the duplex ultrasound. Therefore, clinical surveillance alone may lead to an unnecessary delay in repeat
interventions or predispose patients to unnecessary invasive examinations. In particular, diabetic patients and
those with ischaemic tissue loss might beneﬁt from duplex surveillance to ensure sufﬁcient revascularisation for
ulcer healing.Objective: Despite the popularity of endovascular therapy (EVT) for critical limb ischaemia (CLI), there are few
studies investigating the efﬁcacy of duplex ultrasound (DUS) surveillance after endovascular interventions. The
aim of this study was to evaluate DUS surveillance after EVT for CLI.
Methods: 146 endovascular procedures in 134 consecutive patients with CLI between 2011 and 2012 were
included. Follow-up visits with ankle-brachial index (ABI), toe pressure, and target vessel DUS were performed at
1, 3, and 6 months after revascularisation.
Results: The median age of the study population was 79 years, 58% were males, and 55% had diabetes. The
target artery was at the iliac, femoro-popliteal, and infrapopliteal level in 2%, 54%, and 44% of cases, respectively.
There were 282 follow-up visits. In 15 (5.3%) DUS examinations, the target vessel was not seen properly. In the
remaining 267 DUS, the majority of the target arteries were patent with no or mild restenosis (n ¼ 169, 63.3%),
but in 98 (36.7%) examinations, the target artery was stenosed or occluded. When DUS was compared with the
clinical presentation, there was no correlation in 30% and when DUS and toe pressure were compared,
discrepancy was seen in 29%. A re-angiogram was performed for 29 patients, and the DUS ﬁnding was veriﬁed in
each case. During the mean follow-up of 11 months, a new endovascular intervention was performed on 37
(25.3%) limbs, and 4 (2.7%) underwent surgical bypass. Four (3.0%) patients died and 6 (4.5%) underwent major
amputation.
Conclusion: Clinical status or toe pressure alone were adequate markers of endovascular revascularisation failure
in the majority of the patients, but would have missed up to one-third of the clinically signiﬁcant restenoses or
occlusions. DUS is therefore a valuable aid in surveillance after EVT for CLI, especially for patients with an
ischaemic tissue lesion.
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Surveillance after revascularisation for critical limb
ischaemia (CLI) aims for sustained patency of the revascu-
larisation as well as the continued best medical care of the
patient. In addition to early technical failures, the patency
of revascularisation can be jeopardised later by a ﬂow-
limiting stenosis caused by intimal hyperplasia. In veinresponding author. E. Saarinen, Department of Vascular Surgery,
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//dx.doi.org/10.1016/j.ejvs.2014.01.012grafts, this hyperplasia develops as a response to arteriali-
sation and to surgical trauma. Analogously, intimal thick-
ening of the target artery is triggered by local trauma
caused by angioplasty or irritation by a stent. These ste-
noses can be non-invasively detected by means of colour
duplex ultrasound. There are four randomised controlled
trials1e4 assessing the efﬁcacy of systematic duplex sur-
veillance after infrainguinal vein bypass. Although endo-
vascular revascularisation has replaced bypass surgery as
the ﬁrst-line treatment method for CLI, there are no RCTs
and only few other studies5,6 investigating the role of
duplex ultrasound (DUS) surveillance after endovascular
interventions. We launched DUS surveillance after endo-
vascular interventions for CLI at the beginning of 2011 and
Table 1. Demographic data of the study population.
Demographics n %
Age (years), median (range) 79 (50e101)
Male sex 77 57.5
Diabetes 74 55.2
CAD 75 56.0
Hypertension 103 76.9
Current smoking 38 28.4
Indication
Rest pain 35 24.0
Ulcer 92 63.0
Gangrene 19 13.0
Target artery levela
Iliac 3 2.1
Femoro-popliteal 79 54.1
Infrapopliteal 64 43.8
CAD ¼ coronary artery disease.
a The most distal target artery in the case of multilevel disease.
Table 2. Procedural details.
n %
Lesion type
Stenosis 44 30.1
Occlusion 102 69.9
Treatment
POBA 126 86.3
DEB 3 2.1
Stent 17 11.6
Initial result
0e20% residual stenosis 126 86.3
20e50% residual stenosis 18 12.3
>50% residual stenosis 2 1.4
DEB ¼ drug eluting balloon; POBA ¼ plain old balloon angioplasty.
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veillance is worthwhile. In particular, the aim of this study
was to assess the usefulness of colour duplex surveillance
after endovascular revascularisation for critical limb
ischaemia.
MATERIALS AND METHODS
A total of 146 endovascular procedures performed on 134
consecutive patients with critical limb ischaemia between
2011 and 2012 at Helsinki University Central Hospital were
included in this single-centre study. Demographic data,
procedural details, postoperative outcome, and follow-up
data were prospectively collected into our institutional
vascular and endovascular database (Husvasc) and scruti-
nised retrospectively. The study was approved by the
institutional review board of Helsinki University Central
Hospital (Department of Surgery).
Endovascular interventions were performed in an angi-
ography suite by interventional radiologists or vascular
surgeons. Access was achieved by either antegrade punc-
ture or retrograde puncture from the contralateral side,
depending on the target lesion location. Prior to lesion
recanalisation, 5000 IU of heparin was administered. The
lesion was treated according to the operating radiologist’s
or surgeon’s preference e the most common method was
balloon angioplasty; stents were used selectively and drug
eluting balloons were opted for in cases of restenosis. An-
tiplatelet medication was not discontinued before the
procedure. For patients on aspirin, clopidogrel was pre-
scribed after the procedure for 1 month after iliac pro-
cedures, for 3 months after SFA procedures, and for 6
months after infrapopliteal procedures. Similarly, for pa-
tients on warfarin, additional aspirin was prescribed for 1e
6 months depending on lesion location. Patients were dis-
charged on the day of the procedure or the next day, and
the ankle-brachial index (ABI) and toe pressure (TP) were
measured prior to discharge. For those patients with
ischaemic gangrene, wound debridement was performed
and in cases of infection, targeted antibiotic therapy was
prescribed. Dedicated wound management, including
negative pressure wound therapy (NPWT) and skin grafts,
were used for patients with tissue loss.
Follow-up was at 1, 3, and 6 months after revascular-
isation. At each follow-up visit, the clinical status (ulcer
healing, resolution of rest pain) was registered, ABI and toe
pressure were measured, and the target artery was scanned
with duplex ultrasound. Duplex scanning was performed by
a vascular surgeon. The duplex ﬁnding was compared with
the completion angiogram to distinguish restenosis from
residual stenosis. Stenoses were considered signiﬁcant
(>50%) if the velocity ratio (Vr) was >2 or if the peak
systolic velocity was >180 cm/s.5 In cases of signiﬁcant
restenosis, clinical status was always taken into consider-
ation when deciding on whether to perform re-angiography
or not. Three categories were used when assessing the
clinical status. The status was considered improved if rest
pain had resolved and/or the ischaemic tissue lesion had
healed or was signiﬁcantly smaller than preoperatively. Ifthe clinical status was neither better nor worse, it was
considered unchanged. A recurrence of rest pain that had
already resolved or a deteriorating ulcer/gangrene was
considered a deterioration in the clinical status. If the pa-
tient underwent a re-intervention, the surveillance pro-
gramme re-started from the beginning.RESULTS
The median age of the study population was 79 years
(range 50e101). Fifty-eight per cent of the subjects were
male, and 55% had diabetes. The indication for treatment
was rest pain (24%), ulcer (63%), or gangrene (13%). The
location of the most distal target artery was at the iliac,
femoro-popliteal, and infrapopliteal level in 2%, 54%, and
44% of the cases, respectively (Table 1). Thirty per cent of
the lesions were stenoses and 70% were occlusions. Most of
the lesions (86.3%) were initially treated with plain balloon
angioplasty, and the initial success rate was considered
good (residual stenosis 0e20%) in 86.3% (Table 2).
Most of the patients (n ¼ 100; 74.6%) had two surveil-
lance visits (at 1 and 6 months [n ¼ 71], at 1 and 3 months
[n ¼ 9], or at 3 and 6 months [n ¼ 20]). Twenty-eight
(20.9%) patients had only one surveillance visit (at 1
month [n ¼ 20], at 3 months [n ¼ 8]), and 18 (13.4%) had
Table 3. Duplex ﬁndings at each follow-up (FU) visit.
At 1 month
FU (n ¼ 118)
At 3 months
FU (n ¼ 55)
At 6 months
FU (n ¼ 109)
No visibility 7 (5.9) 3 (5.5) 5 (4.6)
Patent, no
restenosis
84 (71.2) 32 (58.2) 53 (48.6)
Restenosis 23 (19.5) 12 (21.8) 34 (31.2)
Occlusion 4 (3.4) 8 (14.5) 17 (15.6)
Data are given as n (%).
420 E. Saarinen et al.three control visits (at 1, 3, and 6 months). Altogether, there
were 282 surveillance visits. Duplex ﬁndings at each follow-
up visit are presented in Table 3.
In 15 (5.3%) DUS examinations, the target vessel (distal
superﬁcial femoral artery [n ¼ 1], proximal anterior tibial
artery [n ¼ 3], proximal posterior tibial artery [n ¼ 3],
proximal ﬁbular artery [n ¼ 8]) was not seen clearly enough
to perform ﬂow measurements. In the remaining 267 DUS
examinations, the majority of the endovascularly treated
arteries were patent with no or mild restenosis (n ¼ 169,
63.3%), but in 98 (32.4%) examinations, the target artery
was severely stenosed or occluded (Fig. 1). When the
patency ﬁnding in DUS was compared with the clinical
presentation (pain, wound healing, limb status), there was
no correlation in 30% of the cases, and when the patency
was analysed using toe pressures (toe pressure during the
surveillance visit was compared with the preoperative
value), discrepancy was seen in 29% of cases (Fig. 1).
Of the 98 limbs, which had a signiﬁcant restenosis
(n ¼ 69) or occlusion (n ¼ 29) on DUS, angiography was
performed on those 29 limbs that had either deteriorated
or unchanged clinical status. The angiography showed oc-
clusion or signiﬁcant restenosis in a previously treated
segment in all except one case which had stenosis in
another location. A new endovascular intervention was
performed on all except one limb, which was treated byFigure 1. This ﬁgure summarises the duplex ﬁndings (DUS) and
adjacent clinical and vascular laboratory ﬁndings (toe pressures).bypass to the posterior tibial artery (Table 4). Of those 21
limbs that had restenosis (n ¼ 19) or occlusion (n ¼ 2) at 1
month but did not undergo re-angiography because of good
clinical status, seven (33%) had deteriorated limb status
later (3 at 3 months and 4 at 6 months) and duplex revealed
that in four cases, a stenosis had progressed to an occlu-
sion. Similarly, of those 12 limbs that had restenosis
(n ¼ 10) or occlusion (n ¼ 2) at 3 months but did not un-
dergo re-angiography at that time, two (17%) had later
deterioration of limb status.
During the mean follow-up of 11 months, a repeat or a
new endovascular intervention was performed on 37
(25.3%) limbs, and four (2.7%) underwent surgical bypass.
Four (3.0%) patients died and six (4.5%) underwent major
amputation.DISCUSSION
The endovascular approach to the management of critical
limb ischaemia has gained widespread popularity, and in
recent years it has become the most common ﬁrst-line
treatment at the authors’ institution. Despite the
immense increase in endovascular procedures, the optimal
surveillance method, as well as optimal length of surveil-
lance, remains controversial. It is believed that collateral
preservation after endovascular revascularisation may
diminish the clinical signs of restenosis or occlusion. Hence,
duplex surveillance after endovascular revascularisation is
considered less important, as the same result might be
achieved with clinical surveillance only.7 This is probably
true when CLI patients presenting with rest pain are
considered. However, CLI patients with tissue lesions are
more difﬁcult to evaluate. The expected ischaemic tissue
lesion healing time is long, even after successful revascu-
larisation.8 Moreover, it is our experience that the increase
in ABI and toe pressures after endovascular revascularisa-
tion is less intense or slower than after surgical bypass. In
the current study, we showed that, on the basis of clinical
status alone, the patency of the treated lesion is difﬁcult toTable 4. This table summarises angiogram ﬁndings and re-
interventions. Duplex surveillance led to re-angiogram in 29
(19.8%) patients.
At 1 month
FU (n ¼ 118)
At 3 months
FU (n ¼ 55)
At 6 months
FU (n ¼ 109)
Re-angiogram 6 8 15
Target lesion
Patent, no
restenosis
0 0 1a
Restenosis 4 2 8
Occluded 2 6 6
Re-intervention 6 7 15
POBA 3 4 10
DEB 3 2 4
Stent 0 1 1
DEB ¼ drug eluting balloon; FU ¼ follow-up; POBA ¼ plain old
balloon angioplasty.
a Target lesion was patent, but there was stenosis in more distal
part of the target artery.
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and toe pressures did not correlate with the DUS ﬁnding.
Therefore, clinical surveillance alone may lead to an un-
necessary delay in repeat interventions for these patients or
predispose patients to unnecessary invasive examinations
with the risk of complications. In particular, this applies to
diabetic patients, whose ulcer healing time is even longer,8
and it is thus especially important to reliably ensure the
sufﬁciency of revascularisation.
In 2011, Humphries et al.6 suggested that selective early
DUS screening may be beneﬁcial after interventions as early
duplex is able to reveal a residual stenosis missed on
completion angiography in 50% of the patients. Moreover,
these signiﬁcant residual stenoses on the duplex scan were
associated with a signiﬁcantly higher amputation rate
compared with a normal early duplex scan (20% vs. 5%). The
European guideline for the treatment of CLI from 20117 also
suggests that an early colour duplex scan is useful after
endovascular interventions for CLI in order to identify those
revascularisations at risk of failure; however, evidence
supporting long-term duplex surveillance after endovascular
revascularisation is lacking. Moreover, this guideline rec-
ommends close surveillance particularly for diabetic pa-
tients because of possibly impaired patency and unreliable
ankle-brachial indices.9
In the present study, 25% of the patients underwent a
repeat endovascular procedure during the mean follow-up
of 11 months. There are studies reporting even higher re-
intervention rates, up to 35%, within 1 year of endovas-
cular revascularisation for CLI.9,10 This emphasises the
importance of early detection of failing revascularisations to
avoid delay in re-intervention, as several re-interventions
may be needed to sustain re-established circulation and
to avoid amputation.
Duplex surveillance after endovascular interventions dif-
fers from the surveillance of vein grafts because the exact
localisation of the treated arterial segment as well as dis-
tinguishing between residual stenosis and restenosis can be
difﬁcult. It can also be challenging to measure ﬂow from
deeply located and usually heavily calciﬁed infrapopliteal
arteries. In this study, 5% of the duplex examinations failed
because the target vessel could not be visualised
adequately. Duplex surveillance is also examiner-
dependent, and the learning curve is relatively long.
The ﬂaws of the present study include the relatively small
number of patients, the lack of a control group, and the rather
short follow-up time. Furthermore, thereweremissingABI and
toe pressure values. The limb salvage rate during the mean
follow-up timeof 11monthswas 95.9% in this series. However,
it is not clear whether this good result is because of DUS sur-
veillance or systematic surveillance per se or is a consequence
of the optimal patient selection for endovascular therapy.
After vein bypass, evidence suggests that long-term
duplex surveillance is not needed for good-quality grafts if
the early duplex scan is normal.7,11 However, the same does
not necessarily apply to endovascular interventions because
of limited long-term patency. In this study, most occlusions
were detected at 6 months after revascularisation. Theoptimal timing and duration of DUS surveillance remains to
be assessed and there is deﬁnitely a need for a randomised
controlled trial comparing DUS surveillance and clinical
surveillance only, with particular interest in relevant end-
points such as limb salvage and wound healing rate.
CONCLUSION
Clinical status or toe pressure alone were adequate markers
of endovascular revascularisation failure in most patients,
but would have missed up to one-third of the clinically
signiﬁcant re-stenoses or occlusions. DUS is therefore a
valuable aid for surveillance after endovascular revascular-
isation for CLI. In particular diabetic patients and those with
ischaemic tissue loss might beneﬁt from duplex surveillance
to ensure sufﬁcient revascularisation for ulcer healing.
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